NRx Pharmaceuticals, Inc.
NASDAQ:NRXP · NASDAQ Global Market
+$0.06 today
Vol 0.78M · Avg 1.27M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+28.06%
Period High
$4.62
Period Low
$1.68
Latest
$3.97
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Karyopharm Therapeutics Inc.
NASDAQ:KPTI
$208.25M
Century Therapeutics, Inc.
NASDAQ:IPSC
$197.55M
Equillium, Inc.
NASDAQ:EQ
$107.81M
Cue Biopharma, Inc.
NASDAQ:CUE
$71.24M
Spruce Biosciences, Inc.
NASDAQ:SPRB
$70.29M
Outlook Therapeutics, Inc.
NASDAQ:OTLK
$64.18M
Coeptis Therapeutics, Inc.
NASDAQ:COEP
$55.98M
Senti Biosciences, Inc.
SNTI
$24.61M
Werewolf Therapeutics, Inc.
HOWL
$16.92M
IO Biotech, Inc.
IOBT
$885,690.00
What is the latest NRXP filing?
The latest filing shown is 8-K dated Jun 4, 2026.
How many recent filings does NRXP have?
Intrinsic Alpha currently shows 20 recent filings for NRXP.
Explore More
Continue the stock analysis
Jump to another research area for this company.